TORONTO, CULT Food Science Corp. ("CULT" or the "Company") (CSE: CULT) (OTC: CULTF) (FRA: LN00), a disruptive food technology platform pioneering the commercialization of lab grown meat and cellular agriculture to reshape the global food industry, is thrilled to announce that its subsidiary, Further Foods Inc., has completed and submitted the feeding trial design protocol for dog food products containing cell-cultivated chicken to the FDA.
Key Takeaways
- The protocol for Further Foods' first of its kind feeding trial to scientifically validate cultivated chicken in dog food products has been officially completed and submitted to the FDA. Further Foods aims to start feeding trials in Q4 2024, pending approval of the protocol from the FDA.
- Further Foods continues to collaborate with leading vet nutritionist Dr. Sarah Dodd on all aspects of the feeding trial in order to ensure the highest standards of safety and nutritional efficacy.
- This feeding trial is a crucial step towards Noochies! bringing cultivated meat pet food products to pet owners in North America, ensuring it is safe and effective.
The trial is anticipated to be a 26-week, minimally invasive study involving 30 healthy, adult dogs of various breeds and ages. The trial will monitor feed intake data, hematology, serum biochemistry, urinalysis, weight, fecal analysis, and digestibility factors to ensure the inclusion of cell-cultivated meat is safe for the animals. Further Foods has partnered with Dr. Sarah Dodd to ensure the feeding trial design meets all FDA requirements.